143 related articles for article (PubMed ID: 15906759)
1. Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice.
Caronna R; Diana L; Nofroni I; Sibio S; Catinelli S; Sammartino P; Chirletti P
Dig Dis Sci; 2005 May; 50(5):868-73. PubMed ID: 15906759
[TBL] [Abstract][Full Text] [Related]
2. Gabexate mesilate (FOY) inhibition of amylase and phospholipase A(2) activity in sow pancreatic juice.
Caronna R; Loretta D; Campedelli P; Catinelli S; Nofroni I; Sibio S; Sinibaldi G; Chirletti P
J Invest Surg; 2003; 16(6):345-51. PubMed ID: 14708545
[TBL] [Abstract][Full Text] [Related]
3. A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study.
Gao HJ; Song Q; Lv FQ; Wang S; Wang YR; Luo YK; Mei XG; Tang J
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):707-711. PubMed ID: 26489626
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of gabexate mesilate (FOY) against impaired pancreatic energy metabolism in rat acute pancreatitis induced by caerulein.
Hirano T; Manabe T; Tobe T
Life Sci; 1991; 49(22):PL179-84. PubMed ID: 1719326
[TBL] [Abstract][Full Text] [Related]
5. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
Freise J; Schmidt FW; Magerstedt P; Schmid K
Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
Freise J
Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
Schädlich HR; Büchler M; Beger HG
Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
[TBL] [Abstract][Full Text] [Related]
8. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
[TBL] [Abstract][Full Text] [Related]
9. The effect of continuous arterial infusion of gabexate mesilate (FOY-007) on experimental acute pancreatitis.
Satoh H; Harada M; Tashiro S; Shiroya T; Imawaka H; Machii K
J Med Invest; 2004 Aug; 51(3-4):186-93. PubMed ID: 15460905
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of gabexate mesilate (FOY) against pancreatic injuries induced by ethanol in rats.
Hirano T
Nihon Geka Hokan; 1994 Jan; 63(1):10-20. PubMed ID: 7826181
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
Nishijima J; Okamoto M; Nakaguchi K; Ogawa M; Yamano T; Mori T
Gen Pharmacol; 1985; 16(3):177-82. PubMed ID: 3926598
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
Freise J; Wittenberg H; Magerstedt P
Klin Wochenschr; 1989 Feb; 67(3):149-52. PubMed ID: 2467043
[TBL] [Abstract][Full Text] [Related]
13. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
Hirano T; Manabe T; Tobe T
J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
[TBL] [Abstract][Full Text] [Related]
14. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
Hesse B; Lankisch PG; Kunze H
Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic secretion in the rat influenced by the low molecular weight serine proteinase inhibitor Gabexate mesilate.
Keim V; Göke B
Eur J Clin Invest; 1986 Dec; 16(6):519-25. PubMed ID: 3104052
[TBL] [Abstract][Full Text] [Related]
16. Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of acute pancreatitis.
Chen HM; Shyr MH; Chen MF
J Formos Med Assoc; 1997 Sep; 96(9):704-9. PubMed ID: 9308324
[TBL] [Abstract][Full Text] [Related]
17. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.
Chen CC; Wang SS; Tsay SH; Lee FY; Lu RH; Chang FY; Lee SD
Cytokine; 2006 Jan; 33(2):95-9. PubMed ID: 16473521
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of determination of serum immunoreactive pancreatic phospholipase A2 content for early identification of severe acute pancreatitis.
Matsuda Y; Ogawa M; Nishijima J; Miyauchi K; Mori T
Hepatogastroenterology; 1986 Oct; 33(5):214-6. PubMed ID: 2433200
[TBL] [Abstract][Full Text] [Related]
19. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
Freise J; Melzer P; Schmidt FW; Horbach L
Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum amylase and gabexate mesilate with endoscopic papillary balloon dilatation.
Sato Y; Okamura S; Nakasono M; Aoki R; Nakamoto J; Muguruma N; Ito S
J Med Invest; 2007 Feb; 54(1-2):65-71. PubMed ID: 17380016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
